Literature DB >> 9413284

The amyloid beta protein induces oxidative damage of mitochondrial DNA.

P Bozner1, V Grishko, S P LeDoux, G L Wilson, Y C Chyan, M A Pappolla.   

Abstract

Multiple lines of evidence suggest involvement of oxidative stress in the pathogenesis of Alzheimer disease (AD). The finding that amyloid beta peptide (A beta) has neurotoxic properties and that such effects are mediated in part by free-radicals has provided an avenue to explore new therapeutic strategies. In this study, we showed that exposure of PC 12 cells to an A beta fragment induces oxidative damage of mitochondrial DNA. Cells were exposed for 24 h to 50 microM A beta (25-35) or to 50 microM of a control peptide with a scrambled sequence. Oxidative damage of mitochondrial DNA (mtDNA) was assessed using a Southern blot technique and an mtDNA-specific probe recognizing a 13.5-kilobase restriction fragment. Treatment of DNA with NaOH was used to reveal abasic sites and single strand breaks. Treatment with endonuclease III or FAPy glycosylase was used to detect pyrimidine or purine lesions, respectively. Cells exposed to A beta exhibited marked oxidative damage of mtDNA as evidenced by characteristic changes on Southern blots. Cells exposed to the scrambled peptide did not show such modifications. Simultaneous addition of the pineal hormone melatonin consistently prevented the A beta-induced oxidative damage to mtDNA. Mitochondrial dysfunction in AD has been demonstrated by several laboratories. This study provides experimental evidence supporting a causative role of A beta in mitochondrial lesions of AD.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9413284     DOI: 10.1097/00005072-199712000-00010

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  20 in total

1.  Transgene delivery with a cationic lipid in the presence of amyloid beta (betaAP) peptide.

Authors:  P S Ajmani; W Wang; F Tang; M A King; E M Meyer; J A Hughes
Journal:  Neurochem Res       Date:  2001-03       Impact factor: 3.996

Review 2.  Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment.

Authors:  M Flint Beal
Journal:  J Bioenerg Biomembr       Date:  2004-08       Impact factor: 2.945

3.  RPA physically interacts with the human DNA glycosylase NEIL1 to regulate excision of oxidative DNA base damage in primer-template structures.

Authors:  Corey A Theriot; Muralidhar L Hegde; Tapas K Hazra; Sankar Mitra
Journal:  DNA Repair (Amst)       Date:  2010-03-24

Review 4.  Mitochondrial medicine for aging and neurodegenerative diseases.

Authors:  P Hemachandra Reddy
Journal:  Neuromolecular Med       Date:  2008-06-20       Impact factor: 3.843

5.  Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity.

Authors:  I I Kruman; C Culmsee; S L Chan; Y Kruman; Z Guo; L Penix; M P Mattson
Journal:  J Neurosci       Date:  2000-09-15       Impact factor: 6.167

Review 6.  The excitatory neurotransmitter glutamate stimulates DNA repair to increase neuronal resiliency.

Authors:  Jenq-Lin Yang; Peter Sykora; David M Wilson; Mark P Mattson; Vilhelm A Bohr
Journal:  Mech Ageing Dev       Date:  2011-06-25       Impact factor: 5.432

7.  Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo.

Authors:  M A Pappolla; Y J Chyan; R A Omar; K Hsiao; G Perry; M A Smith; P Bozner
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

8.  Enhancement of NEIL1 protein-initiated oxidized DNA base excision repair by heterogeneous nuclear ribonucleoprotein U (hnRNP-U) via direct interaction.

Authors:  Muralidhar L Hegde; Srijita Banerjee; Pavana M Hegde; Larry J Bellot; Tapas K Hazra; Istvan Boldogh; Sankar Mitra
Journal:  J Biol Chem       Date:  2012-08-17       Impact factor: 5.157

Review 9.  Melatonin for Sleep Disorders in Patients with Neurodegenerative Diseases.

Authors:  Lynn Marie Trotti; Elias G Karroum
Journal:  Curr Neurol Neurosci Rep       Date:  2016-07       Impact factor: 5.081

Review 10.  Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment.

Authors:  D Allan Butterfield; Tanea Reed; Shelley F Newman; Rukhsana Sultana
Journal:  Free Radic Biol Med       Date:  2007-06-13       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.